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Human Herpesvirus-6 and Histiocytosis 
Langerhans cell histiocytosis (LC H), a spectrum of disorders in-
volvi ng an abnormal proliferation of Langerhans cells, presents in 
its most aggressive form in infants and toddlers with fever, hepato-
megaly, and skin lesions. It has generally been regarded as a malig-
nant condition, but its exact nature remains controversial. Although 
immunologic dysfunction, possibly triggered by infection, is 
thought to playa role in its pathogenesis, a specific infectious agent 
has not been identified in association with LCH. 
Human herpesvirus 6 (HHV -6), a member of the human herpes-
vi rus fam ily described only in 1986, is the causative agent of the 
childhood exanthem, roseola. Primary infection usually occurs in 
ch i·ldren; this is also the population in which LCH is most fre-
quently found . HHV -6 was originally isolated from patients with 
immune dysfunction, and subsequent studies have provided indirect 
ev idcnce for a causal association of HHV -6 and atypical or malig-
nant lymphohistiocytic processes. Although HHV -6 is a lympho-
trophic virus that specifically targets T cells, it also infects human 
monocytes and macrophages. 
These observations suggested that HHV -6 might be associated 
with LCH. T o test this hypothesis, Leahy et al (p. 642) examined 
involved tissue of patients with LCH for the presence of HHV-6 
DNA using the DNA amplification technique known as the 
polymerase chain reaction (PCR) . In tissue (primarily skin) from 30 
LCH patients, HHV-6 DNA was detected in14 (47%), but the viral 
DNA was found by this technique in only 3 of 63 (S%) biopsies in a 
control group with other cutaneous lymphocytic and histiocytic 
disorders (p < 0.001) . These preliminary but exciting findings em-
phasize the need for furth er investigation of the possible role of 
HHV -6 in the pathogenesis of LCH and in immune regulation in 
humans. HHV -6 has also been associated recently with pneumoni-
tis after bone marrow transplantation (N EnglJ Med 329: lS6 -1 61, 
1993) and with an infectious mononucleosis-like syndrome (N Engl 
] Med 329:168-171,1993). 
Tanning Is Enhanced by a DNA Repair Enzyme 
Although suntanning has been studied extensively, its molecular 
mechanism remains unknown. Experiments in animals and humans 
over many decades have established that ultraviolet (UV) irradiation 
increases melanin synthesis in epidermal melanocytes and transfer 
of melanin to surrounding keratinocytes, producing darkening of 
the skin and decrease in UV sensitivity. More recent work with 
cultured melanocytes has demonstrated that at least part of the me-
lanogenic response is a direct effect of photons on the melanocyte, 
because isolated melanocytes irradiated in vitro respond with in-
creased melanin content and dendricity, just as they do in IIivo . 
Teleologically, tanning is viewed as a protective response, because 
the melanin polymer is an excellent absorber of energy throughout 
the UV spectrum that might otherwise produce mutagenic or lethal 
lesions in DNA. T4 endonuclease S (T4NS) is a bacterial DNA 
repair enzume that catalyzes the first and rate: limiting step in repair 
of the principal UV -induced DNA lesion, the thymine dimer. If 
this enzyme is delivered to cells in liposomes, it enhances repair of 
UV-induced DNA damage in cultured cells and in skin. In this 
issue, Gilchrest and co-workers (p. 666) now report that treatment 
of cultured human melanocytes and murine melanoma cells with 
Iiposomes carrying T4NS enhances UV-induced melanogenesis. 
The fact that T4N5 is known to enhance thymine dimer repair and 
is thought only to mediate DNA repair suggests that DNA is the 
molecular target for UV-induced melanogenesis and that thYmi-
dine dimer repair is involved in tanning . In bacteria, thymidine 
dimer excision is accompanied by an "SOS" response that includes 
ac tivation of more than 20 genes whose activation produces aug-
mented cell survival following UV irradiation. An analogous SOS 
response in humans has not been described, although multiple genes 
are activated by UV. It is tempting, however, to speculate that 
tanning might be part of such a protective cellular mechanism. The 
resul ting increase in melanin would protect cells from 5l1bsequenr 
UV exposure. The observation that T4NS in liposomes enhances 
melanogenesis in cultured irradiated cells suggests that topical ap-
plication of lIposome-encapsulated endonuclease to human skin 
might augment tanning and thereby decrease damage from subse-
quent sun exposure whil e also enhancing repair of DNA damage 
incurred during the initial exposure. 
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The Behavior of Hair Follicle Stem Cells In Vitro 
I 1990 Cotsarelis, Sun, and Lavker described a subpopulation of 
n ter root sheath cells that are "slow-cycling" with respect to the 
oUll cycle-an important property of stem cel ls ill vivo (Cell ~~ .1329 - 1337, 1990). Based on these and other data, the authors 
r~ osed that hair follicu lar stem cells may reside in the bulge (or 
RJulst " in the ongmal German lIterature, an enlargement of the 
ter root sheath at the site of attachment of the arrector pili mus-
°lu) rather than in the hair matrix, as has been thought previously. 
'be e important prediction of this hypothesis is that the bulge, 10-~ed in the upper part of the follicle, should contain at least some 
~a atinocytes with superior ill vitro growth potential. In this issue, 
.;rng Lavker, and Sun (p. 652) compared the ill lIit ro proliferative 
a en'tial of keratinocytes microdissected from different parts of h~~an scalp hair follicles. They found that kertinocytes from the 
upper part of the follicle do indeed have a longer il"l vitro lifespan 
than keratinocytes from the lower part of the follicle, the matrix, or 
the sebaceous gland. An unexpected and potentially important 
aspect of their work is that they found that these upper follicular 
keratinocytes survived ill lIitro even better than keratinocytes from 
the interfollicular epidermis. These results provide additional sup-
port for the idea that hair follicle stem cells reside in the upper part 
of the follicle, where the bulge is found. In addition, their data raise 
the intriguing possibility that follicle stem cells may not only give 
rise to new follicular downgrowth during early anagen, but also 
may be involved in the long-term maintenance of the epidermis . 
The data may also have important implications in the areas of 
wound healing and epidermal diseases. 
Direct Effects of N europeptides on Keratinocytes 
E idermal keratinocytes are. known to synthesize and secret~ several 
p urotrophic factors mcludmg nerve growth factor, suggestmg that ke atinocytes may guide and/or support survival of peripheral neu-
er s. On the other hand, many neuropeptides are known to be 
ron d f .. d leased from cutaneous neurons an may unctIOn as Immunomo -r~ tors in some dermatoses, a possibility referred to as "neurogenic ~ flammation." The direct effects of neuropeptides on epidermal 
~ratinocytes are only ~e~inning to be examined. ~n this i.ssue, by 
demonstrating changes mmtracellula: cycbc AMP m keratmocytes 
treated with neuropeptIdes, TakahashI et at (p. 646) S~10~ that neur-
o eptides act directly on l:uman keratmocytes. Calclt~mn ~e~e re-
l!red peptide, vasoactive lIltest1l1al. peptIde, and peptlde-hl.st~d1l1e 
methionine were shown both to actIvate adenylyl cyclase actIvity 111 
cell membranes and to increase intracellular cyclic AMP. The acti-
vation of adenylyl cyclase was found to be a direct effect, because it 
was mediated through cell surface receptors. Neuropeptide Y was 
shown to inhibit adenylyl cyclase activity, and this inhibitory effect 
on cyclic AMP synthesis was eliminated by pretreatment of cultured 
cells with glucocorticoid. Takahashi et al show that the growth of 
cultured keratinocyte cell lines is stimulated by the application of 
CGRP and VIP, which elevate intracellular cyclic AMP. These 
findings suggest that neuropeptides may be involved in the patho-
genesis of some hyperproliferative skin diseases, such as psoriasis. In 
this condition, the amounts of neuropeptides have been reported to 
be increased in skin lesions, and anti-neuropeptide drugs such as 
capsaicin may be beneficial. 
EDITORIAL 
Biogenic Amine Metabolism and Neurodermatology 
There are many clues suggesting that the skin provides a crucial link 
between the environment and the peripheral and central nervous 
systems. Like the study ofT~kahash! et al (p. 646) on ne~ropeptides, 
the article by Gaudet et at 111 tl11S Issue (p. 660) prOVides further 
evidence for the neurobiologic importance of the skin. The skin is 
richly innervated and pos~esse~ the capacity to respond to a b~oad 
range of environmental stImult, among the~l ther~al , ~echamcal, 
and noxious. The apparent close embryologiC relatIOnshIp between 
cells of the neural crest and melanocytes and Merkel cells indicates 
that the skin and the nervous system are intimately interconnected. 
Indeed, it is now clear that neuropeptides such as substance P are 
present in the skin and are involved in neurotransmission and in 
influencing selected types of inflammatory responses. 
The study of Gaudet et at demonstrates the presence of two iso-
zymes of arylamine N-acetyltransferase (NAT), enzymes that ace-
tylate biogenic amines such as serotonin and dopamine. Serotonin is 
an intermediate in the synthesis of melatonin, an indoleamine that 
can function as a neurotransmitter and also as a hormone affecting 
sleep. Dopamine or a metabolite may influence some types of vascu-
lar responses in the skin. These results strongly suggest that mam-
malian skin is capable of metabolizing biogenic amines and provide 
further evidence for the skin's ability to modify the chemical milieu 
within the end-organ itself. Further work is needed to define the 
importance of biogenic amine metabolism in the skin, but these 
findings provide further evidence for the growing recognition of 
the skin as a neurobiologic entity. 
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